OBJECTIVE: To assess the clinic value of a single maternal serum beta-human chorionic
gonadotropin (2-hCG) assay 11 d after embryo transfer in ART pregnancies and to predict …

Purpose: Our purpose was to assess the predictive value for pregnancy outcome of an initial
serum quantitative β-hCG measurement obtained 11 or 12 days after embryo transfer in an …

Objective: To determine the predictive value (s) of β–hCG serum levels for pregnancy
outcome following blastocyst transfer. Design: Retrospective review. Setting: University …

Objective To investigate the pregnancy outcomes of patients with low serum β-hCG level 14
days after day 3 embryo transfer. Methods A retrospective study was performed with 723 …

Serum level of beta-subunit of human chorionic gonadotropin (beta-hCG) at the post-ET day
16 was studied to evaluate its predictability of pregnancy outcome in 165 patients in vitro …

Purpose To evaluate the relationship between serum β-human chorionic gonadotropin
(HCG) levels and early pregnancy outcomes in women who became pregnant using …

Objective It has been reported that the quantitative serum hCG level 14 days after embryo
transfer (ET) correlated with pregnancy outcome as well as a likelihood of a multiple …

Objective To investigate the value of serum beta-human chorionic gonadotropin (β-HCG) on
days 9 (d9) and 11 (d11) after fresh embryo transfer (ET) and frozen-thawed embryo transfer …

Background Although prior work has attempted to predict pregnancy outcomes by assaying
serum β-hCG levels after blastocyst transfer, no study has focused on pregnancy outcomes …

Objective: This study was designed to evaluate the predictive value of β-hCG levels in
predicting the pregnancy outcome. Methods: A retrospective analysis was done on 423 …